SULLIVAN LARA (Chief Executive Officer) sold 0.4% of their position (8.64K shares) of PYXIS ONCOLOGY, INC. on the open market
Open‑market sale worth $18.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/18/2023ACC: 0001209191-23-049826
DirectorOfficer· Chief Executive Officer
Since Oct 2021
-8.64K
Net shares
Net seller
$18.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.64K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−100.00
Price / share
$2.25
Trade value
$225.00
% of position
0.0%
9/14/2023
2.41M→2.41M
Common Stock
Direct
Shares
−8.54K
Price / share
$2.10
Trade value
$17.94K
% of position
0.4%
9/18/2023
2.41M→2.40M
Total
Net shares
−8.64K
Net value
-$18.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2023 | S · Sale | −100.00 | $2.25 | $225.00 | 0.0% | 2.41M | 2.41M |
| Common Stock Direct | 9/18/2023 | S · Sale | −8.54K | $2.10 | $17.94K | 0.4% | 2.41M | 2.40M |
| Total | −8.64K | -$18.16K | ||||||
Derivative Transactions0
No derivative transactions reported